Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4278
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChang, Anneen
dc.date.accessioned2022-11-07T23:51:10Z-
dc.date.available2022-11-07T23:51:10Z-
dc.date.issued2019en
dc.identifier.citation54 , 2019, p. S29-S30en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/4278-
dc.description.abstractPBB is clinically defined as (a) the presence of isolated chronic ( > 4 weeks) wet/productive cough, (b) resolution of cough with antibiotic treatment and (c) absence of pointers suggestive of an alternative specific cause of cough. While the original description1 included a criteria that required findings from bronchoalveolar lavage (BAL), it was later adapted for clinical use in the same year as undertaking BAL routinely in a child with chronic wet or productive cough is unwarranted and not feasible. PBB has been officially recognized in chronic cough guidelines of many countries and a European Respiratory Society (ERS) taskforce document has also been produced.2 Currently, suggestions for classifying PBB are PBBclinical, PBB-micro, PBB-extended and recurrent PBB.3 Children with PBB are typically very young (median age ∼2 years) and may have parent-reported wheeze. The reported 'wheeze' may actually be a rattle (reflective of airway secretions) and not a true wheeze.4 However, children with PBB may have co-existent asthma, although in a prospective cohort study, median peripheral blood eosinophils, total IgE and RAST testing for common aeroallergens in children with PBB were similar to controls.5 The chest X-rays of children with PBB may be reported as 'normal' but usually show peribronchiolar changes. In many children, co-existent trachea-bronchomalacia6 is present although we found no significant difference in the frequency of trachea-bronchomalacia between children with PBB and 'non-PBB controls' (children with respiratory symptoms but did not have PBB).5 Common respiratory pathogens found in the bronchoalveolar lavage (BAL) of children with PBB are H. influenza (mostly nontypeable), S. pneumoniae and M. catarrhalis. In the original description of PBB,1 children who had the classical respiratory viruses detected by PCR were excluded, so as to obtain a 'clean group'. In PBB, the child's cough resolves only after a prolonged course (usually 2 weeks) of appropriate antibiotics7 with resultant improved cough-specific and generic health-related quality of life measures.3 Some children required up to 4 weeks of antibiotics. Anecdotal experience suggests that when shorter courses of antibiotics are used, the cough subsides but does not resolve and/or resolves but recurs very quickly. Reasons for this are unknown but one postulate is that longer courses of antibiotics are required to overcome the bacteria associated with formation of biofilms, demonstrated in the BAL of children without cystic fibrosis or Pseudomonas aeruginosa infection.3 Some children with PBB have recurrent episodes ( > 3/y) and some progress to bronchiectasis.8 Thus, children with PBB should be clinically reviewed. Predictors of disease progression are recurrence ( > 3/y) and presence of non-typeable H. influenzae in the BAL.8 Further, while chronic wet/productive cough in children often signify PBB, wet cough could also be the marker of other conditions. Readers are referred to recent publications for reasons outlining how and why PBB is closely linked with bronchiectasis as a continuum.3,9 This was first proposed a decade ago4 and recent studies support this, as recently summarized.3,10 The clear reason why the motion for the strong link between PBB and bronchiectasis should be supported is that Prof. Bush has coauthored a review regarding the paradigm of the spectrum linking PBB with bronchiectasis as a continuum with chronic endobronchitis being the common thread.10 This paradigm is based on decades-old and more recent studies using new technology. It is framed around the notion that primary prevention of bronchiectasis is possible and the knowledge that early detection of causal conditions (eg hypogammaglobulinemia) substantially reduces the risk of the future development of bronchiectasis through early initiation of treatment and optimal care. In children, mild (ie when detected early) bronchiectasis is potentially reversible. 9,10 Many factors influence progression of the illness, most of which are modifiable and represent potential inter ention points. These factors (secondary prevention) include better clinical management and guideline implementation. The paradigm emphasizes that prompt diagnosis and optimal management of bronchiectasis is particularly important in childhood with opportunities for its reversal of bronchiectasis and/or halting disease progression.9,10.L6287105342019-08-05 <br />en
dc.language.isoenen
dc.relation.ispartofPediatric Pulmonologyen
dc.titleProtracted bacterial bronchitis and links with bronchiectasis-PRO/CON Debate 1.1. PBB-a precursor to bronchiectasis? (Pro)en
dc.typeArticleen
dc.identifier.doi10.1002/ppul.24371en
dc.subject.keywordsbodily secretionsen
dc.subject.keywordsbronchiectasisen
dc.subject.keywordsbronchomalaciaen
dc.subject.keywordschilden
dc.subject.keywordschronic coughen
dc.subject.keywordsclinical articleen
dc.subject.keywordscohort analysisen
dc.subject.keywordsconference abstracten
dc.subject.keywordscontrolled studyen
dc.subject.keywordscystic fibrosisen
dc.subject.keywordsdisease exacerbationen
dc.subject.keywordseosinophilen
dc.subject.keywordsfemaleen
dc.subject.keywordshumanen
dc.subject.keywordsimmunoglobulin deficiencyen
dc.subject.keywordsinfectious agenten
dc.subject.keywordsinfluenzaen
dc.subject.keywordslung lavageen
dc.subject.keywordsmaleen
dc.subject.keywordsmotionen
dc.subject.keywordsnonhumanen
dc.subject.keywordspolymerase chain reactionen
dc.subject.keywordsprecursoren
dc.subject.keywordspreschool childen
dc.subject.keywordsprimary preventionen
dc.subject.keywordsprospective studyen
dc.subject.keywordsPseudomonas infectionen
dc.subject.keywordspublicationen
dc.subject.keywordsquality of lifeen
dc.subject.keywordsrelapseen
dc.subject.keywordssecondary preventionen
dc.subject.keywordsthorax radiographyen
dc.subject.keywordstracheaen
dc.subject.keywordsvirusen
dc.subject.keywordswheezingen
dc.subject.keywordsasthmaen
dc.subject.keywordsairwayen
dc.subject.keywordsimmunoglobulin Een
dc.subject.keywordsantibiotic agentendogenous compounden
dc.subject.keywordsbiofilmen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L628710534&from=exporthttp://dx.doi.org/10.1002/ppul.24371 |en
dc.identifier.risid760en
dc.description.pagesS29-S30en
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

66
checked on Feb 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.